Aifa ordered the withdrawal from pharmacies and the distribution chain of certain batches of the anti-ulcer drug with ranitidine due to carcinogenic impurities, namely due to the presence of an impurity called N-nitrosodimethylamine, which belongs to the class of nitrosamines contained in the active principle of ranitidine.
We see the features and amount of the seized drug and the subject of warning
Following voluntary withdrawal notifications from Laboratori Guidotti Spa, here are a few drugs that are covered by the warning:
1) ULCEX 150 mg cpr AIC 025084017, Lot No. 162 expires 11-2019
2) ULCEX 150 mg cpr AIC 025084017, lot No. 186, shelf life 06-2021
3) ULCEX 150 mg cpr AIC 025084017, lot number 186 / A, shelf life 06-2021
4) ULCEX 300 mg cpr AIC 025084056, lot No. 171, shelf life 05-2020
5) ULCEX 300 mg cpr AIC 025084056, lot No. 171 / A, shelf life 05-2020
Ranitidine is an inhibitor of acid secretion, which is used in the treatment of ulcers, gastroesophageal reflux, heartburn. This should not cause problems when ingested in small quantities, but when ingested in excessive quantities, according to animal studies, it is probably classified as carcinogenic. It is present in some foods and in water.
We advise consumer gentlemen and, for greater peace of mind, to check whether they own the listed parties and have grounds for warning, just go to the pharmacy and replace them with medicines that are not related to the warning areas.
Even a month ago, ranitidine did not have a big shock throughout Europe for drugs manufactured in factories in India, so there was a general warning to launch a control of all drugs for the possible presence of nitrosamines,
High blood pressure drug withdrawn from sale in pharmacies: that's all
To keep abreast of events, subscribe to us: facebook – twitter – GNews – Instragram – Pinterest – Youtube – contact us on Whatsapp for a new number 3516559380 – enter this number in the address book and send us the following message through WhatsApp: "news", we will reply as soon as possible.